Editorial Commentary: Pediatric Acute Kidney Injury: Is the Addition of Gentamicin Worth the Risk?

Clin Infect Dis. 2015 Oct 1;61(7):1125-6. doi: 10.1093/cid/civ466. Epub 2015 Jun 16.

Authors

Sara Van Driest¹, Jennifer L Goldman²

Affiliations

¹ Department of Pediatrics, Division of General Pediatrics and Department of Medicine, Division of Clinical Pharmacology, Vanderbilt University Medical Center, Nashville, Tennessee.
² Children's Mercy Hospitals and Clinics, Department of Pediatrics, Divisions of Pediatric Infectious Diseases and Clinical Pharmacology, University of Missouri-Kansas City.

No abstract available

Keywords: gentamicin; pediatric acute kidney injury.

Publication types

Editorial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Acute Kidney Injury / chemically induced*
Anti-Bacterial Agents / adverse effects*
Bacteremia / drug therapy*
Enterococcus faecalis*
Gentamicins / adverse effects*
Gram-Positive Bacterial Infections / drug therapy*
Humans

Substances

Anti-Bacterial Agents
Gentamicins

Grants and funding